Is Sree Rayalaseema Hi-Strength Hypo a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Sree Rayalaseema Hi-Strength Hypo Ltd is a good quality company .

Is Sree Rayalaseema Hi-Strength Hypo undervalued or overvalued?

The key valuation ratios of Sree Rayalaseema Hi-Strength Hypo Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone .

What is Sree Rayalaseema Hi-Strength Hypo share price return in the past 10 years?

Sree Rayalaseema Hi-Strength Hypo Ltd share price has appreciated 26.8% annually (CAGR) over the past ten years.

Is Sree Rayalaseema Hi-Strength Hypo a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Sree Rayalaseema Hi-Strength Hypo Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

What is the P/E ratio of Sree Rayalaseema Hi-Strength Hypo?

The latest standalone P/E ratio of Sree Rayalaseema Hi-Strength Hypo as of 13-Nov-2024 is 16.08.

What is the P/B ratio of Sree Rayalaseema Hi-Strength Hypo?

The latest standalone P/B ratio of Sree Rayalaseema Hi-Strength Hypo as of 13-Nov-2024 is 1.50.

What is the 52-week high and low of Sree Rayalaseema Hi-Strength Hypo?

The 52-week high of Sree Rayalaseema Hi-Strength Hypo is Rs. 943.95 and the 52-week low is Rs. 438.95.

What is the TTM revenue of Sree Rayalaseema Hi-Strength Hypo?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Sree Rayalaseema Hi-Strength Hypo is Rs. 773.83 (Cr.).

Sree Rayalaseema Hi-Strength Hypo Ltd - Stock Valuation and Financial Performance

Name: Sree Rayalaseema Hi-Strength Hypo
Brand: Sree Rayalaseema Hi-Strength Hypo

BSE: 532842 | NSE: SRHHYPOLTD | Chemicals | Small Cap

Place order

Sree Rayal.Hi-Strent Share Price

₹672.85 -31.50 -4.47%
as on 13-Nov'24 11:43

10 Year X-Ray of Sree Rayal.Hi-Strent:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis ^P

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
ROCE % ⓘ	15.4%	13.8%	8%	13.4%	15%	15.2%	21.4%	27%	29%	14.4%	-
Value Creation Index ⓘ	0.1	0.0	-0.4	0.0	0.1	0.1	0.5	0.9	1.1	0.0	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	392	363	366	546	702	689	911	1,267	1,650	866	774
Sales YoY Gr.	-	-7.4%	0.8%	49%	28.6%	-1.9%	32.2%	39.1%	30.2%	-47.5%	-
Adj EPS ⓘ	11.1	13.4	13.6	14.8	10.5	21.6	34.7	59.3	83.3	51.2	44.6
YoY Gr.	-	20.5%	1.9%	8.5%	-28.6%	105.2%	60.5%	71%	40.5%	-38.5%	-
BVPS (₹) ⓘ	116.7	127.6	150.7	193.7	189.5	181.5	226.1	332.3	437.6	467.3	479.2
Adj Net Profit ⓘ	16.3	19.7	21.1	24.1	18.1	37.1	59.5	102	143	88	77
Cash Flow from Ops. ⓘ	43	14.8	47	5.1	59.8	99.3	70.5	60.1	131	132	-
Debt/CF from Ops. ⓘ	2	5.8	1.2	15.3	0.9	0.5	0.9	0.3	0.1	0	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	9.2%	4.3%	-1.7%	-47.5%
Adj EPS ⓘ	18.6%	37.2%	13.9%	-38.5%
BVPSⓘ	16.7%	19.8%	27.4%	6.8%
Share Price	26.8%	45.7%	25.6%	17%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
Return on Equity % ⓘ	10.2	10.9	9.9	8.7	5.6	11.7	17	21.3	21.7	11.3	9.4
Op. Profit Mgn % ⓘ	10.4	12.2	13.5	8.4	14	14.8	14.3	11.7	10.9	12.8	13.2
Net Profit Mgn % ⓘ	4.2	5.4	5.8	4.4	2.6	5.4	6.5	8	8.7	10.2	9.9
Debt to Equity ⓘ	0.5	0.5	0.2	0.3	0.2	0.2	0.2	0	0	0	-
Working Cap Days ⓘ	114	125	115	92	98	110	92	105	105	160	127
Cash Conv. Cycle ⓘ	26	39	33	30	38	45	43	46	42	64	114

Recent Performance Summary

Net Profit is growing at healthy rate in last 3 years 13.89%

Return on Equity has declined versus last 3 years average to 9.40%

Sales growth has been subdued in last 3 years -1.67%

Sales growth is not so good in last 4 quarters at -40.15%

Latest Financials - Sree Rayalaseema Hi-Strength Hypo Ltd.

	Standalone	Consolidated
TTM EPS (₹)	44.6	42.7
TTM Sales (₹ Cr.)	774	774
BVPS (₹.) ⓘ	479.2	477.3
Reserves (₹ Cr.) ⓘ	805	802
P/BV ⓘ	1.50	1.50
PE ⓘ	16.08	16.80

From the Market
52 Week Low / High (₹)	438.95 / 943.95
All Time Low / High (₹)	10.85 / 950.80
Market Cap (₹ Cr.)	1,231
Equity (₹ Cr.)	17.2
Face Value (₹)	10
Industry PE ⓘ	55.4

Management X-Ray of Sree Rayal.Hi-Strent:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Sree Rayal.Hi-Strent

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Sree Rayal.Hi-Strent

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Sales	392	363	366	546	702	689	911	1,267	1,650	866
Operating Expenses ⓘ	352	319	317	500	604	587	781	1,119	1,470	755
Manufacturing Costs	52	48	48	66	103	101	125	120	136	141
Material Costs	215	192	191	346	397	377	547	848	1,163	479
Employee Cost	16	14	16	19	21	23	25	29	39	35
Other Costs ⓘ	68	66	62	69	83	86	83	122	133	100
Operating Profit ⓘ	41	44	50	46	98	102	130	149	180	111
Operating Profit Margin (%)	10.4%	12.2%	13.5%	8.4%	14.0%	14.8%	14.3%	11.7%	10.9%	12.8%
Other Income ⓘ	2	4	2	3	2	4	7	11	35	24
Interest ⓘ	14	11	8	9	16	10	5	3	5	4
Depreciation ⓘ	10	10	25	19	45	50	51	19	19	11
Exceptional Items ⓘ	7	-1	-4	15	3	0	0	0	0	-11
Profit Before Tax ⓘ	26	26	15	37	42	45	81	137	190	109
Tax ⓘ	6	7	-4	0	22	8	20	34	36	28
Profit After Tax	19	19	18	37	20	38	61	103	154	80
PAT Margin (%)	4.9%	5.1%	5.0%	6.7%	2.9%	5.5%	6.7%	8.1%	9.4%	9.3%
Adjusted EPS (₹)	13.2	12.7	11.9	22.5	11.9	22.1	35.3	59.9	89.9	46.9
Dividend Payout Ratio (%)	11%	12%	13%	9%	17%	11%	9%	6%	4%	6%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Equity and Liabilities
Shareholders Fund	172	188	233	316	325	312	388	570	751	802
Share Capital ⓘ	15	15	15	16	17	17	17	17	17	17
Reserves ⓘ	157	173	218	300	308	294	371	553	734	785
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	68	73	50	70	46	40	61	19	8	0
Long Term Debt	39	27	20	22	6	1	1	0	0	0
Short Term Debt	28	46	29	48	40	39	61	18	8	0
Trade Payables	46	24	35	23	42	25	12	77	70	13
Others Liabilities ⓘ	73	72	46	64	75	97	118	212	252	155
Total Liabilities ⓘ	358	357	364	472	487	473	579	878	1,081	970
Fixed Assets
Gross Block	293	302	314	344	389	406	405	443	434	438
Accumulated Depreciation	98	107	132	150	195	244	295	313	332	342
Net Fixed Assetsⓘ	194	195	182	194	194	161	110	130	102	95
CWIP ⓘ	5	2	8	0	0	3	0	0	0	0
Investmentsⓘ	23	23	43	105	65	18	50	164	268	253
Inventories	25	22	29	37	37	37	40	144	126	32
Trade Receivables	35	53	30	57	88	82	97	132	149	107
Cash Equivalents ⓘ	6	6	15	10	15	86	139	113	229	334
Others Assetsⓘ	69	56	56	70	88	85	143	195	207	149
Total Assets ⓘ	358	357	364	472	487	473	579	878	1,081	970

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Cash Flow From Operating Activity ⓘ	43	15	47	5	60	99	71	60	131	132
PBT ⓘ	26	26	15	37	42	45	81	137	190	109
Adjustment ⓘ	25	19	31	9	57	58	52	14	5	-4
Changes in Working Capital ⓘ	-3	-14	7	-46	-29	6	-25	-59	15	56
Tax Paid ⓘ	-6	-7	-6	4	-11	-11	-37	-32	-79	-28
Cash Flow From Investing Activity ⓘ	-5	-3	-19	-27	-24	-38	-115	-1	-99	-8
Capex	-22	-7	-19	-28	-45	-8	-20	-14	5	-9
Net Investments	17	4	0	-1	21	-31	-99	9	-10	-12
Others ⓘ	0	0	0	1	0	1	4	4	-94	14
Cash Flow From Financing Activityⓘ	-39	-12	-19	16	-37	-22	10	-52	-20	-22
Net Proceeds from Shares ⓘ	0	0	12	6	6	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	-22	-11	-5	1	-16	-5	0	0	0	0
Interest Paid ⓘ	0	0	-6	-7	-16	-9	-5	-2	-2	-4
Dividend Paid ⓘ	-2	-3	-3	-3	-4	-4	-4	-5	-6	-7
Others ⓘ	-15	1	-17	18	-8	-4	19	-44	-12	-11
Net Cash Flow ⓘ	-1	0	8	-6	-1	40	-35	7	12	103

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Ratios
ROE (%)	12.07	10.41	8.73	13.33	6.37	11.91	17.32	21.45	23.36	10.36
ROCE (%)	15.4	13.81	8.01	13.39	14.99	15.15	21.42	27	28.95	14.43
Asset Turnover Ratio	1.13	1.07	1.09	1.32	1.46	1.43	1.73	1.74	1.69	0.85
PAT to CFO Conversion(x)	2.26	0.79	2.61	0.14	3	2.61	1.16	0.58	0.85	1.65
Working Capital Days
Receivable Days	27	42	39	29	38	45	36	33	31	54
Inventory Days	24	22	24	22	19	20	15	26	30	33
Payable Days	41	41	50	30	30	32	12	19	23	32

Sree Rayalaseema Hi-Strength Hypo Ltd Stock News

Sree Rayalaseema Hi-Strength Hypo Ltd FAQs

What is the share price of Sree Rayal.Hi-Strent?

Company share prices are keep on changing according to the market conditions. The closing price of Sree Rayal.Hi-Strent on 13-Nov-2024 11:43 is ₹672.9.

What is the market cap of Sree Rayal.Hi-Strent?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 13-Nov-2024 11:43 the market cap of Sree Rayal.Hi-Strent stood at ₹1,231.5.

What is the P/E ratio of Sree Rayal.Hi-Strent?

The latest P/E ratio of Sree Rayal.Hi-Strent as of 13-Nov-2024 11:43 is 16.08.

What is the P/B ratio of Sree Rayal.Hi-Strent?

The latest P/B ratio of Sree Rayal.Hi-Strent as of 13-Nov-2024 11:43 is 1.50.

What is the 52-week high and low of Sree Rayal.Hi-Strent?

The 52-week high of Sree Rayal.Hi-Strent is ₹944.0 and the 52-week low is ₹438.9.

What is the TTM revenue of Sree Rayal.Hi-Strent?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Sree Rayal.Hi-Strent is ₹773.8 ( Cr.) .

About Sree Rayalaseema Hi-Strength Hypo Ltd

Sree Rayalaseema Hi-Strength Hypo, the torch bearer of the conglomerate, is the only Indian manufacturer of Calcium Hypochlorite, and one of the very few in the world. A state-of-the-art sodium process technology developed through in-house R&D efforts helps the company in manufacturing the product with a chlorine content of 65% to 70%.

Sree Rayalaseema Hi-Strength Hypo exports Calcium Hypochlorite to countries all across the globe viz., Australia, Bangladesh, Belgium, Brunei, China, Colombia, Cyprus, Durban, England, France, Germany, Hungary, Iran, Kenya, Korea, Malaysia, Mauritius, Netherlands, Oman, Peru, Philippines, Quatar, Sri Lanka, Saudi Arabia, Singapore, Tanzania, Thailand, USA, Vietnam etc. The Certificate of Merit awarded by CHEMEXCIL for outstanding export performance reinforces its status as a recognised export house. CODE OF CONDUCT

Calcium Hypochlorite touches vital facets of human existence and is of proven importance in many areas of day-to-day activity. Sree Rayalaseema Hi-Strength Hypo has a distinctive edge in the manufacture of this product, thanks to the twin advantages of indigenous raw materials' availability and supply of some specialised chemicals by Sree Rayalaseema Alkalies and Allied Chemicals Ltd.

The company is also a front-ranking producer of Monochloro Acetic Acid. Manufactured by the scientific crystallizer technology, the product meets international quality standards. Monochloro Acetic Acid is used by all leading manufacturers of Non-Steroid Anti-Inflammatory Drugs, other pharmaceuticals, pesticides, organic chemicals etc.

Product range of the company includes: